Home > Healthcare > Biotechnology > Biotechnology R&D > Cell Lysis & Disruption Market

Cell Lysis & Disruption Market Share

Report ID: GMI7723
Published Date: Dec 2023
Report Format: PDF

Download Free Sample

Cell Lysis & Disruption Market Share

The cell lysis and disruption industry is characterized by diverse players competing in the industry, leveraging their research capabilities and global presence. Strategic collaborations, product innovations, and regulatory compliance further strengthen their positions. Also, the market is characterized by ongoing technological advancements and a focus on developing safer and more effective products, further intensifying the competitive dynamics in the healthcare sector.

Cell Lysis & Disruption Market Companies

Prominent players operating in the cell lysis and disruption industry is as mentioned below:

Thermo Fisher Scientific, Inc.
Merck KGaA
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche Ltd.
QIAGEN N.V.
Danaher Corporation
Miltenyi Biotec
Claremont BioSolutions, LLC
IDEX
Parr Instrument Company
Covaris, LLC
Cell Signaling Technology, Inc.
Qsonica

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global cell lysis & disruption industry size was valued USD 5.1 billion in 2023 and is expected to reach USD 10.9 billion by 2032, attributed to the expanding biopharmaceutical sector with focus on producing therapeutic proteins, monoclonal antibodies, and vaccines.

The reagent-based segment is expected to account for a revenue of USD 5.9 billion by 2032, these methods offer a cost-effective, simplified, and user-friendly approach, eliminating the need for complex equipment and specialized skills.

In 2023, North America held a significant market share of 37.9% and is anticipated to present lucrative opportunities over 2023-2032, backed by a robust infrastructure supporting cutting-edge R&D, a thriving biotechnology industry, and a well-established healthcare ecosystem.

Thermo Fisher Scientific, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., QIAGEN N.V., Danaher Corporation, Miltenyi Biotec, Claremont BioSolutions, LLC, and IDEX.